BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33892184)

  • 1. A Systematic Review of the Treatment of Uterine Myomas Using Transcervical Ultrasound-Guided Radiofrequency Ablation with the Sonata System.
    Arnreiter C; Oppelt P
    J Minim Invasive Gynecol; 2021 Aug; 28(8):1462-1469. PubMed ID: 33892184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine Myoma Position-based Radiofrequency Ablation (UMP-b RFA): 36 months follow-up clinical outcomes.
    Fasciani A; Turtulici G; Pedullà A; Sirito R
    Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():23-28. PubMed ID: 36527825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcervical radiofrequency ablation of fibroids that are 5 cm or larger in women with abnormal uterine bleeding.
    Piriyev E; Schiermeier S; Bends R; Römer T
    J Gynecol Obstet Hum Reprod; 2022 Feb; 51(2):102303. PubMed ID: 34973479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas.
    Jiang X; Thapa A; Lu J; Bhujohory VS; Liu Y; Qiao S
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():38-43. PubMed ID: 24766899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions.
    Iversen H; Dueholm M
    J Minim Invasive Gynecol; 2017; 24(6):1020-1028. PubMed ID: 28662989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Complications, and Factors Predictive of Response to Treatment with Transvaginal Radiofrequency Ablation for Symptomatic Uterine Myomas.
    Santalla-Hernández Á; Naveiro-Fuentes M; Benito-Villena R; López-Criado MS; González-Paredes A; Fernández-Parra J
    J Minim Invasive Gynecol; 2022 Jun; 29(6):743-752. PubMed ID: 35091094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique.
    Parsons JE; Lau MPH; Martin PJ; Islas Lagos JJ; Aguilar Aguirre JM; Garza Leal JG
    J Minim Invasive Gynecol; 2017; 24(4):579-591. PubMed ID: 28109895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency Ablation of Uterine Myomas and Pregnancy Outcomes: An Updated Review of the Literature.
    Polin M; Hur HC
    J Minim Invasive Gynecol; 2022 Jun; 29(6):709-715. PubMed ID: 35123041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Guided Percutaneous Microwave Ablation for Subserosal Uterine Myomas.
    Yang Y; Hao Y; Zhang J; Han Z; Yu J; Liu F; Ma X; Xu R
    J Minim Invasive Gynecol; 2019; 26(3):544-550. PubMed ID: 29964178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient procedure for the treatment and relief of symptomatic uterine myomas.
    Chudnoff SG; Berman JM; Levine DJ; Harris M; Guido RS; Banks E
    Obstet Gynecol; 2013 May; 121(5):1075-1082. PubMed ID: 23635746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis.
    Liu L; Wang T; Lei B
    J Minim Invasive Gynecol; 2021 Feb; 28(2):218-227. PubMed ID: 33197612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-extirpative Treatments for Uterine Myomas: Measuring Success.
    Cope AG; Young RJ; Stewart EA
    J Minim Invasive Gynecol; 2021 Mar; 28(3):442-452.e4. PubMed ID: 32841756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis.
    Lin L; Ma H; Wang J; Guan H; Yang M; Tong X; Zou Y
    J Minim Invasive Gynecol; 2019; 26(3):409-416. PubMed ID: 30253997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids.
    Hudgens J; Johns DA; Lukes AS; Forstein DA; Delvadia D
    Int J Womens Health; 2019; 11():387-394. PubMed ID: 31308763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata.
    Lukes A; Green MA
    J Gynecol Surg; 2020 Oct; 36(5):228-233. PubMed ID: 33061253
    [No Abstract]   [Full Text] [Related]  

  • 16. A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas.
    Fasciani A; Turtulici G; Siri G; Ferrero S; Sirito R
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32178351
    [No Abstract]   [Full Text] [Related]  

  • 17. Pregnancy Outcomes After Direct Uterine Myoma Thermal Ablation: Review of the Literature.
    Keltz J; Levie M; Chudnoff S
    J Minim Invasive Gynecol; 2017; 24(4):538-545. PubMed ID: 28109894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids.
    Shifrin G; Engelhardt M; Gee P; Pschadka G
    Int J Gynaecol Obstet; 2021 Oct; 155(1):79-85. PubMed ID: 33544889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-guided Microwave Ablation in the Management of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis.
    Liu L; Wang T; Lei B
    J Minim Invasive Gynecol; 2021 Dec; 28(12):1982-1992. PubMed ID: 34197954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas.
    Chudnoff S; Guido R; Roy K; Levine D; Mihalov L; Garza-Leal JG
    Obstet Gynecol; 2019 Jan; 133(1):13-22. PubMed ID: 30531573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.